Eli Lilly (LLY) EVP Patrik Jonsson awarded 4,818 shares in Form 4
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Eli Lilly executive Patrik Jonsson, EVP & President, LLY International, reported an acquisition of company stock through an equity award. On 02/09/2026 he received 4,818.052 shares of common stock at $1,044.67 per share, bringing his directly held stake to 60,646.62 shares, with additional indirect holdings in a 401(k) plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Jonsson Patrik
Role
EVP & President, LLY Int'l
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 4,818.052 | $1,044.67 | $5.03M |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 60,646.62 shares (Direct);
Common Stock — 611.2 shares (Indirect, 401(k))
Footnotes (1)
FAQ
What insider transaction did Eli Lilly (LLY) report for Patrik Jonsson?
Eli Lilly reported that EVP & President, LLY International, Patrik Jonsson acquired 4,818.052 shares of common stock on February 9, 2026. The acquisition was coded as a grant or award, rather than an open-market purchase or sale, and increased his direct share ownership.
Was Patrik Jonsson’s Eli Lilly (LLY) transaction a purchase or a grant?
The transaction was reported with code A, described as a grant, award, or other acquisition. This indicates Jonsson received 4,818.052 Eli Lilly shares as part of compensation or a similar arrangement, not as an open-market cash purchase of common stock.
What positions does Patrik Jonsson hold at Eli Lilly (LLY)?
Patrik Jonsson is identified as an officer of Eli Lilly, serving as EVP & President, LLY International. This senior leadership role is disclosed on the Form 4, which reports his beneficial ownership changes and links the equity grant to his executive position with the company.